Valuation: Stereotaxis, Inc.

Market Cap 101M 90.08M 83.49M 75.65M 142M 9.59B 145M 1B 394M 5.02B 380M 372M 16.01B P/E 2026 *
-4.97x
P/E 2027 * -6.89x
Enterprise Value 101M 90.08M 83.49M 75.65M 142M 9.59B 145M 1B 394M 5.02B 380M 372M 16.01B EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.22x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
1 day-1.16%
1 week-12.43%
Current month-18.84%
1 month-24.94%
3 months-35.59%
6 months-50.82%
Current year-56.60%
1 week 0.95
Extreme 0.95
1.07
1 month 0.95
Extreme 0.95
1.4
Current year 0.95
Extreme 0.95
2.86
1 year 0.95
Extreme 0.95
3.15
3 years 0.95
Extreme 0.95
3.59
5 years 0.95
Extreme 0.95
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
01/07/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-12.43%-66.61%-33.00% 101M
+1.18%+3.79%+27.55%+46.35% 251B
-0.08%+1.37%+7.26%+8.17% 158B
+1.11%+2.42%-1.82%+60.18% 153B
+1.18%+3.97%-54.07%-9.83% 65.29B
+1.00%+4.57%-13.27%-9.97% 51.23B
+0.59%+7.71%+12.31%+57.62% 51.29B
+1.23%+2.20%+18.29%+27.81% 50.27B
+1.83%+0.98%+21.91%+57.99% 47.9B
+1.97%+2.48%+32.35%+75.50% 42.67B
Average +0.14%+1.06%-1.61%+28.08% 87.08B
Weighted average by Cap. -0.30%+2.64%+8.67%+35.99%

Financials

2026 *2027 *
Net sales 34.33M 30.56M 28.32M 25.67M 48.23M 3.25B 49.04M 340M 134M 1.7B 129M 126M 5.43B 45.67M 40.65M 37.67M 34.14M 64.16M 4.33B 65.23M 452M 178M 2.26B 171M 168M 7.22B
Net income -20.13M -17.92M -16.61M -15.05M -28.28M -1.91B -28.76M -199M -78.29M -998M -75.52M -73.95M -3.18B -14.77M -13.14M -12.18M -11.04M -20.75M -1.4B -21.09M -146M -57.42M -732M -55.39M -54.24M -2.34B
Net Debt - -
Projected Income Statement - Annual - Stereotaxis, Inc.
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
21/10/26 $0.9983 -1.16% 636,724
19/10/26 $1.010 0.00% 889,682
16/10/26 $1.010 -3.81% 870,063
15/10/26 $1.050 0.00% 641,345
14/10/26 $1.050 -0.94% 692,256
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Stereotaxis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.010USD
Average target price
3.000USD
Spread / Average Target
+197.03%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Stereotaxis, Inc.
  1. Stock Market
  2. Stocks
  3. STXS Stock